5-chloro-2-methoxy-3-(thiophen-2-yl)pyrido[2,3-g]quinoxaline

ID: ALA3735070

PubChem CID: 127036308

Max Phase: Preclinical

Molecular Formula: C16H10ClN3OS

Molecular Weight: 327.80

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1nc2cc3cccnc3c(Cl)c2nc1-c1cccs1

Standard InChI:  InChI=1S/C16H10ClN3OS/c1-21-16-15(11-5-3-7-22-11)20-14-10(19-16)8-9-4-2-6-18-13(9)12(14)17/h2-8H,1H3

Standard InChI Key:  RDTJWDZJROKPIS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   -2.5978    1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5978   -1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978   -1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1965   -1.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3367   -2.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8044   -3.2906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5524   -1.9903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5469   -0.8772    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1950    1.5032    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1933    2.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0037   -2.7002    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  7 14  2  0
  8 11  2  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 15 19  1  0
  3 15  1  0
 20 21  1  0
  2 20  1  0
  6 22  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3735070

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 327.80

Molecular Weight (Monoisotopic): 327.0233

AlogP: 4.57

#Rotatable Bonds: 2

Polar Surface Area: 47.90

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 0.09

CX LogP: 4.31

CX LogD: 4.31

Aromatic Rings: 4

Heavy Atoms: 22

QED Weighted: 0.51

Np Likeness Score: -1.44

References

1. Briguglio I, Loddo R, Laurini E, Fermeglia M, Piras S, Corona P, Giunchedi P, Gavini E, Sanna G, Giliberti G, Ibba C, Farci P, La Colla P, Pricl S, Carta A..  (2015)  Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.,  105  [PMID:26479028] [10.1016/j.ejmech.2015.10.002]

2. Carta A, Briguglio I, Piras S, Corona P, Ibba R, Laurini E, Fermeglia M, Pricl S, Desideri N, Atzori EM, La Colla P, Collu G, Delogu I, Loddo R..  (2016)  A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems.,  117  [PMID:27161176] [10.1016/j.ejmech.2016.03.080]

Source

Source(1):

• Scientific Literature